Vitamin D and Its Deficiency in Saudi Arabia by Bokhari, Fawzi F. & Albaik, Mai
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
Vitamin D and Its Deficiency in 
Saudi Arabia
Fawzi F. Bokhari and Mai Albaik
Abstract
Vitamin D is a hot topic that has attracted attention over the past 10 years, 
especially since a large proportion of people suffer from this nutrient deficiency. 
Vitamin D deficiency is estimated to be about 1 billion people all over the world 
and 50% in Asia and the Middle East. Saudi Arabia has also demonstrated a high 
prevalence of vitamin D deficiency among healthy Saudi individuals. This chapter 
provides, in detail, a clear and understandable identification of vitamin D, its 
function, source, synthesis, metabolism, status, and deficiency. The chapter also 
focuses on studying vitamin D deficiency in Saudi Arabia based on PubMed’s initial 
research criteria.
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1. Introduction
Vitamin D, “sunshine” vitamin, is a vital topic that has attracted great attention 
of many researchers and the public over the past decades, because a large propor-
tion of the world’s population is deficient in this nutritious element [1]. Vitamin 
D was first discovered at the beginning of the twentieth century in children with 
rickets [2].
Vitamin D is a prohormone steroid and belongs to the fat-soluble vitamins. It is 
responsible for endocrine, paracrine, and autocrine functions [1]. Vitamin D is also 
essential for calcium absorption, bone mineralization, calcium and phosphorus 
homeostasis, hormonal release, nerve conduction, and neuromuscular function [3, 4].
2. Function of vitamin D
Vitamin D is known for its crucial role in bone health about a century ago. 
However, it has also demonstrated its role and effectiveness in extra-skeletal roles of 
vitamin D during the past two decades [5].
2.1 Vitamin D and bone health
Vitamin D regulates physiological functions by controlling the metabolism of 
calcium and phosphates, stimulates growth, and promotes the necessary remodel-
ing of bones and teeth [6]. Vitamin D deficiency is often associated with bone 
disorders (such as rickets, osteomalacia, and osteoporosis); when serum calcium 
decreases, the thyroid gland immediately releases parathyroid hormone (PTH), 
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which acts by stimulating bone reabsorption and reduction of calcium urinary 
excretion [7].
Vitamin D levels are positively correlated with bone mineral density (BMD) [4]. 
Many observational studies have reported relations between chronic lower vitamin 
D concentrations and poorer lower-extremity function, lower muscle strength, 
lower contraction speed, and lower appendicular muscle mass [8]. Vitamin D 
deficiency can put people at risk because of low bone mineral density, osteopenia, 
osteoporosis, and tooth loss [6].
2.2 Vitamin D and non-skeletal diseases
Observational studies have shown associations between the low concentration 
of serum vitamin D and increased risk of cancer, cardiovascular diseases, disorders 
of glucose metabolism, neurodegenerative diseases, and mortality [3]. Vitamin D 
modulates a variety of processes and regulatory systems including host defense, 
inflammation, and immunity and repair, especially patients with lung diseases 
often have low vitamin D serum level [9].
The biological effect of vitamin D on cardiac function is through reduced remod-
eling and fibrosis secondary to negative regulation of renin by vitamin D receptor 
(VDR)-linked gene regulation and through reduced cardiac metalloproteinase 
activities [10]. In addition, many indications support a relation between hypovita-
minosis D and slower nerve conduction and poorer executive functions [8]. VDR are 
also expressed on immune cells (T and B cells, monocytes/macrophages, mast cells, 
and antigen-presenting cells) [10]. Moreover, vitamin D may exert positive effects 
on oral health by affecting the production of antimicrobial peptides [6].
Furthermore, many studies have demonstrated that vitamin D supplementation 
has a beneficial effect in decreasing the mortality rate under multiple factors, by 
influencing the cardiovascular system, immune system, tumor progression, and 
others [11].
3. Source of vitamin D
The main sources of vitamin D are our diet, supplementation, and sun  
exposure [2].
Two dominant forms of dietary vitamin D are vitamins D2 (ergocalciferol) and 
D3 (cholecalciferol) [12]. Vitamin D2 is produced by plants and invertebrates after 
ultraviolet radiation exposure [13]. Vitamin D3 is naturally found in many foods 
(such as oily fish, egg yolks, cod liver oil, cheese, mackerel, salmon, tuna fish, and 
beef liver), fortified foods (margarine, breakfast cereals, dairy products, orange 
juice), and vitamin supplements (both vitamins D2 and D3 are available) [1, 14, 15]. 
Dietary vitamin D provides only 10–20% of circulating levels of vitamin D [13].
The chemical structure of these vitamins (D2 and D3) is similar but differs only 
in their side chains (Figure 1). This structural difference modifies their binding 
to carrier protein vitamin D binding protein (DBP) and their metabolism [16]. 
Vitamin D3 is significantly demonstrated more effective than D2 in increasing serum 
25-hydroxyvitamin D [25(OH)D] concentrations due to several reasons including 
reduced vitamin D2 binding and metabolites to DBP in plasma, a non-physiological 
metabolism, and a shorter shelf life of vitamin D2 [13]; therefore vitamin D3 is 
considered the preferred choice for supplementation [14].
Sun exposure is the chief source of vitamin D via the synthesis in the skin through 
the action of ultraviolet B (UVB) radiation on the precursor of vitamin D3 [4, 17]. The 
Commission Internationale de l’Eclairage (CIE) described the efficiency of vitamin D 
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radiation as the efficiency of each wavelength to synthesize vitamin D in the skin. 
The CIE suggests the efficiency of UVB radiation that covers the spectral range 
(255–330 nm) with a maximum at about 295 nm [1]. A whole-body exposure to UVB 
radiation inducing the light pink color of the minimal erythema dose for 15–20 min is 
able to induce the production of up to 250 μg vitamin D (10,000 IU) [1, 6].
4. Synthesis and metabolism
Vitamin D, either endogenously produced (vitamin D3) or ingested (vitamin D2 
or vitamin D3), must be activated in order to produce its effects [5]. This biological 
activation is performed in a multi-step process (Figure 2).
Firstly, UVB radiation penetrates the epidermis and stimulates the conversion of 
7-dehydrocholesterol (7-DHC) into pre-vitamin D3 [18] which undergoes thermal 
isomerization through a sigmatropic hydride shift into vitamin D3 [13].
Secondly, vitamin D2 or D3 is specifically translocated by DBP into circulation 
and then to the liver for hydroxylation at carbon-25 to form 25-hydroxyvitamin D 
[25(OH)D] mainly by two cytochrome P-450 enzymes (CYP2R1 and CYP27A1) [5]. 
Figure 1. 
The structure of vitamins (D2 and D3).
Figure 2. 
A diagram illustrating the different sources and synthesis of vitamin D.
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[25(OH)D] is an inactive and the most abundant circulating form of vitamin D, and 
it is generally measured when assessing vitamin D status which has a circulating 
half-life of about 15 days [2].
Thirdly, 1,25-dihydroxyvitamin D [1,25(OH)2D], the biologically active form of 
vitamin D, is generated through second hydroxylation that takes place in the kidney 
[6] by the enzyme cytochrome P-450 (CYP27B1) monooxygenase 25(OH)D-1-α-
hydroxylase [13] [1,25(OH)2D], which serves as a hormone to regulate a variety of 
cellular functions in other organs or acts inside the kidneys in an autocrine and/or 
paracrine fashion [5]. Several factors regulate the levels of [1,25(OH)2D], 25(OH)
D-1-α-hydroxylase (whose hydroxylation is activated by PTH), calcitonin (which is 
inhibited by serum levels of calcium), phosphorus, and [1,25(OH)2D] itself [19].
Finally, [1,25(OH)2D] enters the cell by diffusion and binds and activates the 
VDR [20].
5. Vitamin D receptor (VDR)
VDR is a member of the nuclear hormone receptor superfamily and acts as a 
ligand-inducible transcription factor as well as its non-genomic actions outside of 
the nucleus [18, 20]. VDRs are present mostly in body organs such as the colon, 
small intestine, bone, breast, brain, pancreas, pituitary, and muscles [12].
The widespread distribution of VDRs and production of calcitriol may interpret 
the increasing number of diseases related to vitamin D deficiency [12]. Binding of 
calcitriol to VDR prompts the transcription of vitamin D-responsive genes (at least 
913 genes) involved in cell proliferation, differentiation, function, and the renin-
angiotensin system [2, 21].
VDR forms a heterodimer complex with the retinoid X receptor (RXR) capable 
of binding to a vitamin D response element (VDRE) in the promoter region of a 
target gene and thereby regulates transcription of more than thousand genes [20].
6. Factors affecting vitamin D synthesis
Many factors affect vitamin D synthesis and its concentration [1, 3, 6, 11, 
17, 19, 20]: aging (age decreases the capacity of the skin to produce vitamin D 
due to lower availability of 7-DHC), season of the year (autumn and winter), 
weather conditions (cloudiness), geographical locations (higher latitude), sun 
exposure, sunscreen (with a protection factor of 30 reduces above 95% of vitamin 
D synthesis in the skin), skin pigmentation (darker skin needs 3–5 times longer 
sun exposure to synthesize the same amount of vitamin D than light skin since 
melanin absorbs UVB radiation), genetic factors (SNPs and mutations), skin 
damage (burns decrease its production), adiposity (obesity has reduced vitamin 
D levels), workplace (indoor vs. outdoor), lifestyle, physical activity, clothing 
habits, air pollution, smoking, diet and calcium intake, vitamin D supplements, 
and individual height.
7. Vitamin D status
Vitamin D status is best determined by measuring serum 25-hydroxyvitamin D 
[25(OH)D]; a level higher than 50 nmol/L (30 ng/mL) contributes to the optimal 
calcium absorption, fall prevention, and prevention of the fracture [4, 22]. Below 
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this level, PTH levels increase blood circulation, causing secondary hyperparathy-
roidism, and increase the risk of osteoporosis and fractures leading to bone loss. 
In addition, moderate increase of PTH may also enhance insulin resistance, weight 
gain, hypertension, left ventricular hypertrophy, and acute phase response, increas-
ing the risk of ischemic arrhythmias and cardiovascular mortality [4].
According to the Committee of the Institute of Medicine (IOM, USA) and 
the Endocrine Society [19, 23], vitamin D status defined the values lower than 
50 nmol/L (20 ng/mL) as vitamin D deficiency (VDD), while values between 50 
and 75 nmol/L are indicated to vitamin D insufficiency (VDI), and values equal or 
above 75 nmol/L (30 ng/mL) is described as adequate or sufficient vitamin D. The 
IOM adds extra criterion which is severe VDD with 25 nmol/L (10 ng/mL).
Serum [25(OH)D] test is detected by using high-performance liquid chromatog-
raphy/mass-spectrometry (LC/MS) methodology [4, 19] which is recommended by 
the National Diet and Nutrition Survey [19]. The high cost for vitamin D detection 
hampers the diagnosis of vitamin D deficiency. There is a great need to develop a 
specific and cheap testing method [4].
8. Vitamin D deficiency
Most studies have identified the vitamin D insufficiency (VDI) at concentra-
tions of [25(OH)D] less than 75 nmol/L (30 ng/mL) and vitamin D deficiency 
(VDD) at concentrations below 50 nmol/L (20 ng/mL) [1, 4, 10, 17].
Vitamin D deficiency is still a highly prevalent disorder. It is estimated that ~1 
billion people are deficient or have insufficient levels of vitamin, in spite of foods 
fortified with vitamin D and wide supplement intake [2].
VDD is widespread in the whole world as well as predominant in Asia and in the 
Middle East (more than 50% of the population is VDD and about 75% is VDI) [4]. 
VDD is found in 30–50% of otherwise healthy middle-aged to elderly adults [11].
Deficiency of vitamin D can result from many reasons such as dietary inad-
equacy of vitamin D, poor absorption and use, increased requirement, increased 
excretion and catabolism, limited sunlight exposure, and inefficient production 
in the skin. Dietary deficiency of vitamin D is associated with milk allergy, lactose 
intolerance, ovo-vegetarianism, and veganism [1, 4]. In addition, various diseases 
affect the bioavailability of vitamin D, such as gastrointestinal disorders which limit 
its absorption; kidney and liver diseases can prevent the activation of the parenteral 
vitamin D or impair the conversion of vitamin D into its active metabolites [4].
Severe VDD in adults leads to osteomalacia while in children leads to rickets, 
defective bone mineralization, increased bone turnover, increased risk of fractures 
[4], impaired reproductive function, and production of gonadal hormone that 
may affect other organs, e.g., gastrointestinal and renal calcium handling, renal 
CYP27B1 activity, and bone function [20].
In the critical care condition, VDD has been associated with adverse outcomes 
such as infections, longer length of stay, acute kidney injury, and higher  
mortality [10].
9. Vitamin D deficiency in Saudi Arabia
A total of 132 articles studying the deficiency of vitamin D in Saudi Arabia were 
identified based on the initial PubMed search criteria. About 20 studies have inves-
tigated the vitamin D deficiency in healthy individuals living in Saudi Arabia during 
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Subjects Prevalence of 
VDD
[25(OH)D] 
<50 nmol/L
Age group 
(years)
City of Saudi Arabia Year of 
study
Ref.
Men 66.7% 20–40 Tabuk 2018 [24]
59% >21 Riyadh 2017 [25]
74.4% 18–50 Riyadh 2015 [27]
92% 20–23 Riyadh 2013 [35]
87.8% 20–74 Jeddah 2012 [36]
92.6% 18–22 Dammam 2009 [30]
32.5% ≥25 Eastern Province 2009 [37]
Newborns 90% Neonates Riyadh 2013 [38]
88% Neonates Riyadh 2011–
2012
[32]
Children and 
adolescents
63% 1–6 Makkah 2015 [39]
92.5% girls
79.3% boys
13–17 Riyadh 2015 [27]
97.8% girls
92.8% boys
6–15 Western, central, and 
eastern regions (8 
provinces)
2013–
2014
[40]
62.65% girls
40.6% boys
≤15 Different regions 2013 [41]
86.27% 4–15 Jeddah 2010 [42]
To convert (nmol/L) into (ng/ml), divide the value by 2.496.
Table 2. 
Prevalence reports on vitamin D deficiency in healthy men, newborns, children, and adolescents living in 
Saudi Arabia.
Status of women Prevalence of 
VDD
[25(OH)D] 
<50 nmol/L
Age group 
(years)
City of Saudi 
Arabia
Year of 
study
Ref.
Premenopausal 80.5% 20–40 Tabuk 2018 [24]
62% >21 Riyadh 2017 [25]
67.8% 19–25 Tabuk 2016 [26]
74.8% 18–50 Riyadh 2015 [27]
100% 19–40 Riyadh 2012 [28]
78.2% 20–50 Jeddah 2011 [29]
99.03% 18–22 Dammam 2009 [30]
41.2% ≥18 Riyadh 2008 [23]
Postmenopausal 85% 50–79 Jeddah 2011 [29]
86.2% >60 Riyadh 2006–
2011
[31]
Pregnant women 88% >16 Riyadh 2011–
2012
[32]
64.2% 20–40 Al Khafji 2011 [33]
50% 20–49 Riyadh 2010 [34]
To convert (nmol/L) into (ng/ml), divide the value by 2.496.
Table 1. 
Prevalence reports on vitamin D deficiency in Saudi healthy women.
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the past 10 years. These studies have demonstrated a noticeably high prevalence of 
VDD in Saudi women (41.2–100%, Table 1) compared to Saudi men (32.5–92.6%, 
Table 2). Deficiency of vitamin D was not only limited to adults but also included 
newborns (88–90%), children, and adolescents (40.6–97.8%) (Table 2).
10. Vitamin D toxicity and safety limits
Excessive oral supplementation and food fortification of vitamin D may lead 
to toxicity because it raises plasma [25(OH)D] concentrations that exceed DBP 
binding capacity, and free [25(OH)D] concentrations have direct effects on gene 
expression once it enters the target cells [13].
Upper safe limit is 5000 IU a day (and some considered it to be 10,000 IU), 
and the toxicity does not manifest serum levels below 120 ng/mL (300 nmol/L). To 
reach the latter levels, one must ingest vitamin D in excess of 50,000 IU daily for 
several months. Thus, the safety of doses to 5000 IU a day is assured [4].
11. Conclusion
In conclusion, this chapter summarizes that vitamin D is a fat-soluble prohor-
mone and has skeletal and extra-skeletal functions. The main sources of vitamin 
D are sun exposure and diet. Two common types of vitamin D are vitamins D2 
(ergocalciferol) and D3 (cholecalciferol). Vitamins D2 or D3 must be activated to 
produce its effects in a multi-step process. Vitamin D status is determined by serum 
25-hydroxyvitamin D [25(OH)D]; the value lower than 50 nmol/L (30 ng/mL) con-
tributes to vitamin D deficiency. Severe vitamin D deficiency leads to osteomalacia 
in adults, rickets in children, and an increased risk of fractures.
Like other countries in the world, Saudi Arabia suffers from vitamin D defi-
ciency. This chapter illustrates the terrible deficiency of vitamin D for the Saudi 
population for both genders and for different age groups.
To improve the status of vitamin D deficiency, distinct strategies should be 
applied to raise the vitamin D stored as a routine measurement through sunlight 
exposure by increasing daily outdoor activity. Moreover, nutritionists should 
emphasize increased dairy intake, vitamin D supplementation, calcium supplemen-
tation, and vitamin D-fortified foods. Finally, effective educational programs are 
needed at the Saudi national level to raise public awareness of the serious vitamin D 
deficiency problem.
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